Value proposition

Harnessing AI-powered virtual cells to reverse age-driven diseases and aging

Shift Bioscience is harnessing AI-powered virtual cells to reverse age-driven diseases and aging. Cell reprogramming with Yamanaka factors can reverse aging in human cells and increase the lifespan of disease models but its tumor-inducing potential hampers therapeutic development. Shift has harnessed AI-powered virtual cells to reduce centuries of rejuvenation experiments to weeks and decouple the tumor-inducing pathway in human fibroblasts. By targeting aging at a cellular level, Shift is creating a common therapeutic approach to age-driven diseases that enables whole-body rejuvenation, building the conditions required for regulators to indicate aging as a disease.

longevity, reprogamming, machine learning, aging clocks, transcriptomics, and virtual cell